Navigation Links
ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
Date:12/3/2008

RANCHO CORDOVA, Calif., Dec. 3 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that it will hold a conference call on Thursday, December 4, to discuss its announcement regarding a management transition at the Company.

The conference call will begin at 5:30 a.m., Pacific Standard Time (8:30 a.m., Eastern Standard Time). The call can be accessed by calling (800) 860-2422 (domestic) or (412) 858-4600 (international), passcode ThermoGenesis. The webcast will also be available on the Company's website at http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

A replay of the call will be available by calling (877) 344-7529 (domestic), or (412) 317-0088 (international), passcode 385107#, or via the Company's website.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timin
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
2. ThermoGenesis Reports First Quarter 2009 Results
3. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
6. ThermoGenesis Corp. Reports First Quarter 2008 Results
7. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
8. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
9. HMS Holdings Corp. To Present at The 20th Annual Piper Jaffray Healthcare Conference
10. Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing
11. HMS Holdings Corp. to Present at Stephens Inc. Fall Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...n Whitaker, MD, a founder of the alternative healt...tpain.com, a new informational Web site devoted to...lutions. , Potomac, MD (V...er of the alternative health movement, is now a fe...ational Web site devoted to all aspects of joint a...
(Date:7/3/2009)...e health care reform details emerge, more entrepre...ll groups and business insurance premiums. Now, th...sites such as the Small Business Health Insurance ... Minneapolis, Minn. (PRWEB) July 3, 2009 -- The...he House, which has entrepreneurs worried about ho...
(Date:7/2/2009)...rs to Support Principles to Govern Health Insurer ...wire-USNewswire/ -- Nearly nine out of ten voters ... too much influence over how doctors care for thei...rt the concept of a "Health Insurer Code of Conduc...es for health insurance companies with respect to ...
(Date:7/2/2009)...RNewswire-USNewswire/ -- Acetaminophen is an ingre...ion medicines to help relieve pain and reduce feve...name, Tylenol and prescription brand names, Vicodi...the FDA met on June 30, 2009 to address liver rela... committee voted 20-17 to urge the FDA to put a ba...
Breaking Medicine News(10 mins):Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2
..., a bacterium commonly found in hospitals, is beco...reat,// reports the April 2007 issue of Harvard Wo...t a new, more virulent strain may be to blame. Ce...oxins that attack the cells lining the colon. Thos...
...ry patients are more likely to suffer infections a...ng to cardiothoracic surgeons in Victoria. Dr Che...m St Vincent's hospital inMelbourne, and colleague...rtery bypass grafting or heart valvesurgery are 1....
... to predict whether a person is likely to have cor...h carried out by Dr. M. Balasubramanyam and Dr.V.M...ndia) shows that people who are pre-diabetic or wh...s1 and, since these people are prone to CAD, an ea...
...kal’ that is aimed for the diabetics, obese and th... India Pharma - USV Ltd//. Cutkal has a combinatio...is the same that is used in diet colas around the ...1981 and is used in 6,000 products like beverages,...
Other Medicine News:Health News:Obese Heart Patients At Greater Risk 2Health News:New Genetic Biomarkers Could Predict Coronary Heart Disease 2
(Date:6/29/2009)...eeks to Assess RSV Burden in Outpatient Setting Du... Pediatric Research , , GAITHERSBURG, Md., Ju...ce its commitment to pediatric research with today...tive study designed to assess the burden of respir...32-to-35 weeks gestational age (GA) in outpatient ...
(Date:6/29/2009)... for Novel Biotherapeutics Based On Naturally Rese...PRNewswire/ -- Pangu BioPharma, a subsidiary of aT... of its third patent application on proprietary, n...s. Although tRNA synthetases are universal and es...found in all organisms, human synthetases have nat...
(Date:6/28/2009)...RONADO, Portugal, June 29 Data pre...on treatment with the novel,once-daily anti-epil...esulted,in a marked and sustained decrease in sei...ults from the one-year extension of a pivotal Esli...d at the International Congress for Epilepsy in,B...
(Date:6/26/2009)...June 26 Sanofi-aventis...de aware of data associated with a retrospective f...f these data clearly show that no definitive concl...lationship between Lantus(R) (insulin glargine [rD...ies, as the authors of the study point out. , ,...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3Thursday May 22 is Health Care Action Day 19934 1Thursday May 22 is Health Care Action Day 19934 2LPGA Competitors and Friends Come Together for Breast Cancer 19932 1LPGA Competitors and Friends Come Together for Breast Cancer 19932 2Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies 2143 1Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies 2143 2Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies 2143 3Oxidized LDL Cholesterol Linked to Metabolic Syndrome 19929 1Oxidized LDL Cholesterol Linked to Metabolic Syndrome 19929 2Oxidized LDL Cholesterol Linked to Metabolic Syndrome 19929 3
...abled more and more laboratory testing to occur at...oratory is hardly threatened with extinction. Nati...s are busier than ever before, and the huge range ...nd ability to handle very large volumes of tests a... clinical landscape. , ,This is especially tru...
...n this country cause more than 114,000 hospitaliza...ults, bronchitis and pneumonia are the most common...are the sixth leading cause of death in the United...derly and immunocompromised people; however, infec...rious illnesses in any patient. Prompt diagnosis o...
Other Medicine Technology:When Volume Matters, Immunoassay Systems Deliver 2When Volume Matters, Immunoassay Systems Deliver 3Fast, Accurate Influenza A/B Antigen Detection 2Fast, Accurate Influenza A/B Antigen Detection 3
The Wide-Vu magnifier is our most popular Low Vision telescope for reading. It offers a wide field of view than the LVA21 and hence a slightly shorter working distance. The Wide-Vu can be mounted to
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame.
This set is designed to introduce the low vision practitioner to the Keeler telescopic system.
Featuring up to 20 tilting tower illumination allows examination in the vertical, horizontal and oblique sections plus the option to offset the slit for corneal transillumination., ,Filters inclu
Medicine Products: